Data for: REBEn 2022-0728: Effects of auriculotherapy on anxiety and biomarkers in the primary health care: a clinical trial

• Autor(a) principal: Siqueira, Letícia
• Data de Publicação: 2023
• Outros Autores: da Silva, Carina, Drago, Lívia Crespo, Lins, Elisa Mitkus Flores, Martins, Daniel Fernandes, Bobinski, Franciane
• Tipo de documento: Conjunto de dados
• Título da fonte: SciELO Data
• Texto Completo: https://doi.org/10.48331/scielodata.EWMJPB
• topic: Medicine, Health and Life Sciences; Anxiety; Auriculotherapy; Biomarkers; Primary Health Care; Nursing assessment

This study aims to evaluate the effects of auriculotherapy on anxiety and serum levels of Brain Derived Neurotrophic Factor (BDNF), Neuron Specific Enolase (NSE), and S100 calcium binding protein B (S100B) in adults attended in Primary Health Care. The methodology is based on a pre-experimental pilot clinical trial evaluating 19 patients randomly selected. Information was obtained through the State-Trait Anxiety Inventory (STAI®) and the biochemical analysis of BDNF, NSE and S100B serum levels by Enzyme-Linked immunosorbent assay. This study is characterized as a pre-experimental pilot clinical trial with a quantitative approach, carried out in a BHU in the city of Palhoça – Santa Catarina, in which the period of data collection was from July to September 2019. The study was carried out over six weeks: in the first meeting, the FICT were read and signed and the STAI® was applied to assess levels of anxiety and eligibility in the sample; in the second meeting, the sociodemographic questionnaire was applied, blood was collected for analysis of serum BDNF, NSE, and S100B, and treatment with auriculotherapy was started; in the third, fourth, and fifth meetings, the auriculotherapy sessions were repeated; in the sixth meeting, the STAI® was applied again to reassess anxiety levels and blood was collected for post-intervention BDNF, NSE, and S100B analysis. The research was conducted and structured following CONSORT guidelines.